APA (7th ed.) Citation

Masuda, Y. (2018). Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein [Cardiovascular]. The American Society for Pharmacology and Experimental Therapeutics.

Chicago Style (17th ed.) Citation

Masuda, Y. Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein [Cardiovascular]. The American Society for Pharmacology and Experimental Therapeutics, 2018.

MLA (9th ed.) Citation

Masuda, Y. Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein [Cardiovascular]. The American Society for Pharmacology and Experimental Therapeutics, 2018.